Showing results (11-20 of 217) with videos related to
Sort By:
Pageof 22
Biological Chemistry|September 24, 1999
The glycosphingolipidoses-from disease to basic principles of metabolismC G Schuette, T Doering, T Kolter, et al.Proceedings of the National Academy of Sciences of the United States of America|August 4, 1999
A vital role for glycosphingolipid synthesis during development and differentiationT Yamashita, R Wada, T Sasaki, et al.Neurochemical Research|February 11, 1999
Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assayU Bierfreund, T Lemm, A Hoffmann, et al.Journal of Inherited Metabolic Disease|January 27, 2005
Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher diseaseU H Schueler, T Kolter, C R Kaneski, et al.Neurobiology of Disease|December 18, 2003
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3U H Schueler, T Kolter, C R Kaneski, et al.Experimental Dermatology|December 19, 1998
Induction of apoptosis by synthetic ceramide analogues in the human keratinocyte cell line HaCaTM Bektas, Y Dullin, T Wieder, et al.The Journal of Biological Chemistry|January 3, 2001
Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizuresH Kawai, M L Allende, R Wada, et al.The Journal of Clinical Investigation|February 18, 1999
A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorderY Liu, R Wada, H Kawai, et al.Die Naturwissenschaften|September 1, 1980
[Lipid-protein interactions: mechanisms of enzymatic glycolipid catabolism and their genetic restrictive escapes]K SandhoffFEBS Letters|July 14, 1997
Bcl-2 antagonizes apoptotic cell death induced by two new ceramide analoguesT Wieder, C C Geilen, T Kolter, et al.Pageof 22